Montisera management is empowered by our world class Scientific Advisory Board and Senior Advisors. Together these bring vital knowledge from science and business to our activities enabling us to be the best in our class.
Mira Povelainen, CEO
Dr. Povelainen has a PhD in Biotechnology and eMBA from Turku School of Economics. She has background both in science and business analyzing and informatics, with a background in DuPont (Danisco) and Raisio. In Raisio she was Management Team Member of Raisio Northern Europe Business Unit and Benecol Division; Head of R&D and QA activities supporting Raisio Northern and Eastern Europe business units as well as global Benecol business.
HEIKKI VUORIKOSKI, business development director
MSc Heikki Vuorikoski is the founder, owner, and board member of Montisera. He founded the company 2012 through a successful spin-out from a Finnish CRO Pharmatest Services Ltd. Vuorikoski is a serial entrepreneur in bio business, and has founded or co-founded six Finnish CROs during the last 13 years. He has the background in genetics and bioinformatics, and is passioned in taking new ideas towards markets and full utilisation.
the board of directors
Jouni hakanen, chairman of the board
Mr. Jouni Hakanen was elected as the Chairman of the Board of Montisera in April 2017. Mr. Hakanen has more than 25 years’ cross-industry experience in strategy and management positions – the past 20 years as a management and strategy consulting. He is specialized in corporate and digital strategy, technology strategy development, operational effectiveness, IT, M&A and in program management. Mr. Hakanen has been the Managing Director for two international companies in Asia with manufacturing and sales operations to cover South and North East Asia.
Specialties: Digital and corporate strategy, IT strategy and functional strategy development and technology alignment , IT and business transformations, Operational effectiveness, integrated supply chain management , customer relationship management and sales management, and Post merger integration planning and execution & management
kalle reponen, board member
Kalle Reponen is a full-day board professional having his background in globally recognised companies like Metso, Nordea Corporate Finance, Wärtsilä and Valmet Automotive. Currently Mr. Reponen serves as a director of the board or board member in several Finnish companies bringing his agile business skills and experience to the companies.
RAKAN RSHAIDAT, BOARD MEMBER
Dr. Rakan Rshaidat has a Doctor In Pharmacy. In addition to Pharmacy, Dr. Rshaidat has a vast knowledge in pulp, paper and board through his position as a Partner and Managing Director of Omnigroup.
CHRISTINE HAGSTRÖM-NÄSI, BOARD MEMBER
Christine Hagström-Näsi has pioneered the Finnish Biorefinery field. She has coordinated and evaluated large research programmes when she worked as a CEO in Finnish Bioeconomy Cluster FIBIC Ltd (former Forestcluster Ltd).
She has also hold several Manager level positions, and worked as the Director for the Forest and Chemical Industries Section in Tekes, the Finnish Funding Agency for Technology and Innovation.
scientific advisory board
Lauri Kangas, Director of the Scientific Advisory Board
Dr. Kangas is the Former R&D Director of Hormos Ltd. He is also one of the real “bench-to-bedside” researchers in Finland, and holds several international patents in the fields of hormonal diseases, bone biology, and cancer.
Prof. Kalervo Väänänen (pathology, anatomy, bone diseases)
Prof. Pirkko Härkönen (cancer, hormonal diseases)
Prof. Mart Saarma (CNS disorders, Parkinson’s disease)
Prof. Kalervo Kiianmaa (alcoholism, dependency disorders)
Dr. Petri Hyytiä (dependency disorders, alcoholism)
Adjunct Prof. Johanna Tuomela (cancer, hormonal diseases)
Dr. Jenni Bernoulli (in vitro and in vivo disease models)
M.Sc. Yvonne Konkol (urological diseases)
Ville Takio (CNS disorders)